Episode 130: Quality of Life, Patient-Reported Outcomes, and Clinical Trials
Healthcare Unfiltered
00:00
How to Measure Quality of Life in a Phase Three RCT
Chris Booth: I think the default here is we should always measure quality of life. What do patients care about? They want to live well and they want to live longer lives. So when we're testing a new intervention, ideally, we should be measuring both survival andquality of life. Michael Phyllis: The Canadian clinical trials group has a policy that at least in phase three trials, which are randomized trials between two different treatment options, as opposed to early phase trials. In those definitive trials, whereas treatment A versus treatment B to see which one is better. But the deep and very few ever meet that criterion,. We virtually always have a quality of life and point in our phase three
Play episode from 10:59
Transcript
